- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$33.34 BnMarket Estimate, 2026
$35.97 BnMarket Forecast, 2034
$66.09 BnCAGR, 2026–2034
7.90%Executive Summary: Global Infectious Disease Diagnostics Market
- Market Scope: Comprehensive global infectious disease diagnostics market analysis covering product categories, disease application segments, technological assay types, end-user clinical settings, and regional leadership frameworks across major global economies.
- Market Valuation: Valued at USD 33.34 billion (2025), estimated at USD 35.97 billion (2026), and projected to reach USD 66.09 billion by 2034, registering a robust CAGR of 7.9% (2026–2034).
- Primary Growth Drivers: Rising global prevalence of infectious diseases such as HIV, hepatitis, and influenza, alongside increasing demand for rapid and accurate diagnostic testing. Key technological and strategic trends include widespread adoption of molecular assays like PCR and next-generation sequencing, integration of artificial intelligence for enhanced data analysis, and expansion of point-of-care testing to improve accessibility and efficiency in clinical settings.
Key Market Segment Metrics (2026–2034)
| Category | Leading Segment (2025 Position) | Fastest-Growing Segment |
|---|---|---|
| By Product Type | Instruments segment (led the market by product type in 2025) | Reagents segment (expected to grow significantly due to recurring testing demand) |
| By Application & Technology | Hepatitis B application (identified as most lucrative); PCR and next-generation sequencing | Advanced molecular diagnostic platforms and point-of-care testing solutions |
| By End User | Laboratory end-user segment (dominated due to increasing use of automated diagnostics) | Decentralized clinics and point-of-care testing facilities |
| By Region | North America (leads the global market due to advanced healthcare infrastructure) | Europe (with Germany holding the largest regional share) and expanding emerging markets |
Major Market Players & Market Structure
Market Structure: Highly competitive global diagnostics landscape driven by technological advancements, strategic partnerships, and the development of cost-effective diagnostic tools to address distribution challenges and meet the growing demand for rapid testing solutions.
Key Companies: Abbott Laboratories, Roche Diagnostics, Thermo Fisher Scientific, bioMérieux, Danaher Corporation, Becton, Dickinson and Company, Cepheid, Inc., Hologic, Inc., Alere Inc., DiaSorin S.p.A., Quidel Corporation, and Bio-Rad Laboratories, Inc.
Global Infectious Disease Diagnostics Market Size
The size of the global infectious disease diagnostics market was worth USD 33.34 billion in 2025. The global market is anticipated to grow at a CAGR of 7.9% from 2026 to 2034 and be worth USD 66.09 billion by 2034 from USD 35.97 billion in 2026.
MARKET DRIVERS
Growing Adoption of Infectious Disease Diagnostics Driving Market Growth
Most physicians' growing adoption of infectious disease diagnostics is propelling the market growth. In addition, YOY growth in the number of people suffering from infectious diseases in developed economies propels global infectious disease diagnostics market growth. It has led vitro diagnostic device manufacturers to invest in emerging economies.
These companies are trying to develop and commercialize cost-effective tools for infectious disease diagnosis. Disease diagnostics are used to confirm the disease through a quick, precise test result. Being time-consuming, disease diagnostics are on the rise. In addition, infectious disease epidemics are spreading worldwide, leading to increased demand for diagnostic tests. The incidences of malaria, flu, AIDS and other diseases are again rising, creating a robust market for infectious disease diagnostics.
Technological Advancements in Diagnostics Offering Growth Opportunities
The increasing need to develop novel and useful diagnostic techniques due to the consistently rising population diagnosed with contagious diseases is accelerating the growth of the infectious disease diagnostics market during the forecast period. Furthermore, the emergence of faster and more reliable diagnostic techniques and equipment integrated with artificial intelligence and machine learning offers growth opportunities for the global infectious disease diagnostics market.
MARKET RESTRAINTS
High Costs and Distribution Challenges Hampering Market Growth
High costs associated with diagnostic kits are majorly hampering the market growth. In addition, issues associated with the distribution channels in developing countries are another major factor that negatively impacts market growth.
REPORT COVERAGE
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| Segments Covered | By Product, Application, Technology, Traditional Methods, End User, and Region. |
| Various Analyses Covered | Global, Regional, and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Market Leaders Profiled | Abbott Laboratories, bioMérieux SA, Hologic, Inc., Danaher Corporation, Becton, Dickinson and Company, Cepheid, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Alere Inc., DiaSorin S.p.A., Quidel Corporation and Bio-Rad Laboratories, Inc., and Others. |
SEGMENTAL ANALYSIS
By Product Insights
By Application Insights
Based on application, the Hepatitis B segment is the most lucrative and forecasted to register healthy CAGR during the forecast period due to the high prevalence of the disease and increased adoption of advanced diagnostics methods for Hepatitis B. HIV, tuberculosis, and influenza are overgrowing at a high pace. Therefore, it is expected to contribute significantly to the global infectious diagnostics market during the forecast period.
By Technology Insights
Based on technology, the DNA Sequencing segment is estimated to account for the most significant share of the global market during the forecast period. Furthermore, it is likely to display growth at a high CAGR during the forecast period due to cost reduction and technological improvements in next-generation sequencing.
By End User Insights
Based on end-user, the laboratory segment dominated the IDD market in 2025 and is likely to continue the trend during the forecast period owing to the increasing adoption of automated diagnostics technologies in laboratories such as mass spectrometry and PCR.
On the other hand, the hospital segment is anticipated to register a healthy CAGR owing to the factors such as reimbursements offered by the governments, accessibility to the patients, availability of advanced diagnostics equipment in the hospitals, and high flow of patients in hospitals.
REGIONAL ANALYSIS
North America Infectious Disease Diagnostics Market Analysis
Geographically, the North American infectious disease diagnostics market held the largest share of the global IDD market, followed by Europe in 2025 Both regions are projected to witness single-digit growth rates during the coming years. The North American market growth is due to the growing occurrence of contagious diseases and the easy availability of technology instruments. The United States secures the highest demand in the region. In 2014, more than 110,000 deaths occurred due to infectious diseases. Increased incidence of dreadful ailments and the rising need to develop new drugs propel the market's growth rate. For instance, 30 million people in the U.S. alone suffer 7,000 varieties of rare diseases. The Canadian infectious diseases diagnostics market is the fastest growing in North America due to the high awareness levels of practitioners and patients and sophisticated healthcare infrastructure uplifting the market growth.
Europe Infectious Disease Diagnostics Market Analysis
The European infectious diseases diagnostics market was the second largest globally in 2025 and is predicted to showcase a healthy CAGR during the forecast period. The high adoption of premium diagnostic techniques maintains the market share in the region. Germany leads the infectious diseases diagnostics market in the area. The quick increase in the chronic and contagious disease population and advanced technologies escalate market growth. As per the German Diagnostics Industry Association (VDGH), the IVD and reagent market turnover recorded in 2017 amounted to approximately EUR 2-3 billion. The U.K. market witnessed to have rapid growth during the analysis period. The government's measures to develop suitable healthcare infrastructure among the existing economies propel market demand. The Centre for Excellence in Infectious Diseases Research in Liverpool is engaging with companies to promote diagnostics in malaria, TB, HIV, NTDs, and Sepsis.
Asia-Pacific Infectious Disease Diagnostics Market Analysis
Be that as it may, the Asia-Pacific infectious disease diagnostics market is projected to register the highest growth rate in the coming years due to the increased pervasiveness of infectious diseases and tremendous investment opportunities due to a growth in healthcare expenditure. The infectious disease diagnostics market in the Asia-Pacific region is to register a quick growth rate during the estimated period. The increasing frequency of contagious diseases and enormous investment opportunities are due to rising healthcare expenditure. The growing requirement for developing new and valuable diagnostics is an increased population diagnosed with infectious diseases. China is leading the IDD market with impressive market growth. The Chinese government's latest initiative is to mandate that all the blood be tested using nucleic acid technologies by the end of 2015. Acquiring advanced molecular procedures, primarily sexually transmitted diseases such as HIV and bacterial infections, accelerates the market growth. Countries like Japan and India have impressive market growth.
KEY MARKET PARTICIPANTS
Some of the prominent companies dominating the global infectious disease diagnostics market profiled in the report are
- Abbott Laboratories
- bioMérieux SA
- Hologic, Inc.
- Danaher Corporation
- Becton, Dickinson and Company
- Cepheid, Inc.
- Thermo Fisher Scientific Inc.
- Roche Diagnostics
- Alere Inc.
- DiaSorin S.p.A.
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
MARKET SEGMENTATION
This research report on the global infectious disease diagnostics market has been segmented and sub-segmented into the following categories.
By Product
- Instruments
- Reagents
- Services
- Software
By Application
- Hepatitis B
- Hepatitis C
- Human Immunodeficiency Virus (HIV)
- Tuberculosis (TB)
- Chlamydia trachomatis
- Neisseria gonorrhoeae (CT/NG)
- Human papillomavirus (HPV)
- Methicillin-resistant Staphylococcus aureus (MRSA)
- and others (Influenza, Ebola, Typhoid, Malaria, and Dengue)
By Technology
- PCR
- INAAT
- DNA Sequencing
- Hybridization
By Traditional Methods
- Immunodiagnostics
- Microscopy
- Biochemical Characterization
By End User
- Hospital
- Laboratories
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East and Africa